In:
Cancer Nursing, Ovid Technologies (Wolters Kluwer Health), Vol. 42, No. 6 ( 2019-11), p. 430-438
Abstract:
The Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS) was developed to measure symptoms and functions of children with a variety of chronic diseases. As the Chinese version of pediatric PROMIS (C-Ped-PROMIS) measures was developed, the measurement properties of C-Ped-PROMIS have not been demonstrated. Objective The aim of this study was to examine the reliability, validity, and factorial structure of the C-Ped-PROMIS measures in children with cancer in China. Methods A total of 272 children and adolescents were recruited from 3 hospitals in China. The 8 C-Ped-PROMIS measures and Pediatric Quality of Life Inventory General Core Module and Cancer Module were administered in a cross-sectional design. Known-group validity, concurrent validity, and item and scale reliability of these 8 measures were examined by using SPSS 21.0, and factorial structures were tested by using confirmatory factor analysis with Mplus 7.1. Results All 8 C-Ped-PROMIS measures showed good known-group validity as hypothesized ( P 〈 .05) and good concurrent validity measured by significant correlations with the Pediatric Quality of Life Inventory General Core Module and Cancer Module; the correlation coefficients ranged from r = 0.519 to r = 0.655, except for peer relationship with r = 0.255 and r = 0.136, respectively. The Cronbach's α of C-Ped-PROMIS ranged from .758 to .910, and model-estimated scale reliabilities ranged from 0.740 to 0.905. The confirmatory factor analysis models of each measure fit data very well. Conclusions All 8 C-Ped-PROMIS measures have a valid factorial structure as theoretically defined with good reliability and validity. Implications for Practice The C-Ped-PROMIS can be readily used to measure symptoms and functions of children and adolescents with cancer in China.
Type of Medium:
Online Resource
ISSN:
1538-9804
,
0162-220X
DOI:
10.1097/NCC.0000000000000633
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2019
detail.hit.zdb_id:
2049755-6
